70 Years of Levothyroxine
This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first sy...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Springer Nature
2021
|
| Subjects: | |
| Online Access: | OAPEN Library: download the publication OAPEN Library: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | oapen_2024_20_500_12657_47292 | ||
| 005 | 20210315 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20210315s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a 978-3-030-63277-9 | ||
| 020 | |a 9783030632779 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.1007/978-3-030-63277-9 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MJG |2 bicssc | |
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Kahaly, George J. |4 edt | |
| 700 | 1 | |a Kahaly, George J. |4 oth | |
| 245 | 1 | 0 | |a 70 Years of Levothyroxine |
| 260 | |b Springer Nature |c 2021 | ||
| 300 | |a 1 electronic resource (129 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals. | ||
| 536 | |a Merck KGaA | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Endocrinology |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a Endocrinology | ||
| 653 | |a Pharmacology/Toxicology | ||
| 653 | |a Pharmacology | ||
| 653 | |a Thyroid gland | ||
| 653 | |a Hypothyroidism | ||
| 653 | |a TSH | ||
| 653 | |a Thyroid disorders | ||
| 653 | |a Metabolism | ||
| 653 | |a Open Access | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/bitstream/id/9f9750ce-595c-4578-aeec-5239adeb45c8/9783030632779.pdf |7 0 |z OAPEN Library: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/handle/20.500.12657/47292 |7 0 |z OAPEN Library: description of the publication |